Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
Macrogol 3350; Sodium chloride; Potassium chloride; Sodium hydrogen carbonate
Stirling Anglian Pharmaceuticals Ireland Limited
A06AD; A06AD65
Macrogol 3350; Sodium chloride; Potassium chloride; Sodium hydrogen carbonate
6.9 gram(s)
Powder for oral solution
Osmotically acting laxatives; macrogol, combinations
Not marketed
2015-03-13
Stirling Anglian Pharmaceuticals Wecol 6.9 g Module 1.3.1 V019 PACKAGE LEAFLET: INFORMATION FOR THE USER WECOL 6.9 G, POWDER FOR ORAL SOLUTION Macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU TAKE THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you notice any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Wecol is and what it is used for 2. What you need to know before you use Wecol 3. How to take Wecol 4. Possible side effects 5. How to store Wecol 6. Contents of the pack and other information 1. WHAT WECOL IS AND WHAT IT IS USED FOR Wecol is a laxative. This medicine is used in adults, adolescents and elderly to treat: - chronic constipation. - impaction. Impaction is persistent constipation, where a large volume of stools cause a blockage of the rectum and / or colon. It is not recommended for children below 12 years of age. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE WECOL _ _ DO NOT TAKE WECOL IF YOU: - are allergic to Macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride or any of the other ingredients in this medicine (listed in section 6). - have a blockage in your intestine. - have a perforated gut wall. - have a severe inflammatory bowel disease like ulcerative colitis, Crohn's disease or toxic megacolon. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Wecol if you have heart or kidney problems, an impaired gag reflex, difficulty swallowing or suffer from heartburn. When taking Wecol you should continue to take plenty of fluids. The fluid content of Wecol should not replace your regular liquid in Pročitajte cijeli dokument
Health Products Regulatory Authority 10 May 2023 CRN00DFWK Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Wecol 6.9 g powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One sachet of Wecol contains the following active ingredients: Macrogol 3350, 6.563 g Sodium chloride, 0.1754 g Sodium hydrogen carbonate, 0.0893 g Potassium chloride, 0.0233 g Content of electrolyte ions when one sachet is dissolved in 62.5 mL water: Sodium 65 mmol/l Chloride 53 mmol/l Hydrogen carbonate 17 mmol/l Potassium 5.0 mmol/l Excipients with known effect Each sachet contains: 12.22 mg (0.31 mmol) potassium 93.86 mg sodium 0.38 mg sorbitol (E420) For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for oral solution. Free flowing white powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of chronic constipation in adults, adolescents and the elderly. For resolving faecal impaction in adults, adolescents and the elderly. Faecal impaction is defined as refractory constipation with faecal loading in the rectum and/or colon confirmed by physical or radiological examination of the abdomen and rectum. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology CHRONIC CONSTIPATION A course of treatment for constipation does not normally exceed two weeks, although this can be repeated if required. As for all laxatives. Prolonged use is not usually recommended. Extended use may be necessary in the care of patients with severe chronic or resistant constipation, secondary to multiple sclerosis or Parkinson's disease, or induced by regular constipating medication, in particular opioids and antimuscarinics. _Adults, Adolescents and the Elderly_ 2‐6 sachets daily in divided doses, accrding to individual response. For extended use, dose can be adjusted down to 2‐4 sachets daily. Health Products Regulatory Authority 10 May 2023 CRN00DFWK Page 2 of 6 _Children (below 12 years old)_ Not recommended. Alternative products are available for children. FAE Pročitajte cijeli dokument